Evidence map›Paper›PMID 31130074›Full record

ArticleEmerging microbes & infections2019

Enterohemorrhagic

Ruixue Zhou, Zijuan Chen, Doudou Hao, Yu Wang, Yihua Zhang, Xianfu Yi, Liang-Dong Lyu, Haipeng Liu, Quanming Zou, Yiwei Chu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Combined Transcriptomic and Proteomic ofAnimals : an open access journal from MDPI · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Ruixue Zhoua Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Zijuan Chena Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Doudou Haoa Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Yu Wangb Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy , Army Medical University , Chongqing , People's Republic of China.
Yihua Zhanga Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Xianfu Yic School of Biomedical Engineering , Tianjin Medical University , Tianjin , People's Republic of China.
Liang-Dong Lyua Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.ORCID http://orcid.org/0000-0001-6391-6030
Haipeng Liud Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital , Tongji University School of Medicine , Shanghai , People's Republic of China.
Quanming Zoub Department of Microbiology and Biochemical Pharmacy, National Engineering Research Centre of Immunological Products, College of Pharmacy , Army Medical University , Chongqing , People's Republic of China.
Yiwei Chua Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Baoxue Ged Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital , Tongji University School of Medicine , Shanghai , People's Republic of China.
Dapeng Yana Department of Immunology, School of Basic Medical Sciences & Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH , Fudan University , Shanghai , People's Republic of China.
Shanghai Medical College of Fudan University · CNArmy Medical University · CNTongji University · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many pathogens infect hosts through various immune evasion strategies. However, the molecular mechanisms by which pathogen proteins modulate and evade the host immune response remain unclear. Enterohemorrhagic

Indexed as

Host-Pathogen InteractionsImmune EvasionAnimalsEnterohemorrhagic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHEK293 CellsHumansMacrophages, PeritonealMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMiceMice, Inbred C57BLProtein BindingProtein Tyrosine Phosphatase, Non-Receptor Type 6RAW 264.7 CellsEscherichia coli ProteinsMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 6Receptors, Cell SurfaceTir protein, E coliVirulence FactorsEHECimmune evasionITIMSHP-1TAK1Tir

Identifiers

PMID31130074
PMCPMC6542180
OpenAlexW2945703871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.